Ondine Biomedical is a Canadian life sciences company developing light-activated antimicrobial therapies, with its Steriwave product used to reduce pathogens in the nose before surgery. The 5.13% share-price gain on 20 October, 2026 came as investors follow adoption trends.
IXICO is a London-based specialist that analyses brain imaging data for pharmaceutical and biotech companies running clinical trials in neurological diseases. Its services help sponsors measure whether experimental treatments are affecting the brain. The 9.68% share-price gain on 20 October, 2026 returned attention to …
Bioventix is a Surrey-based biotechnology company that creates high-affinity sheep monoclonal antibodies for use in blood tests run on large automated diagnostic analysers. Its antibodies are used in tests for vitamin D, hormones and cardiac markers. The 7.91% share-price gain on 20 October, 2026 …
ProBiotix Health is a life sciences company that develops probiotic formulations designed to support cardiometabolic health, including cholesterol management. It supplies ingredients and finished products to partners in food supplement and nutraceutical markets around the world. The 15.16% share-price gain followed a Q3 trading …
AOTI, Inc. The latest available review suggests the following focus: As of 20 October 2026, the available review did not establish a verified company-specific announcement that conclusively explains a fresh move in AOTI, Inc.. The stock can still attract attention because investors are reassessing …
The rebrand had been flagged in August, when management said a specialist naming agency was developing a new identity for the enlarged group. Its arrival in October gives the market a fresh reason to revisit the story.
LSE:FARN has also remained in the spotlight following its R&D Day on 8 October, when management and external experts set out the case for bexmarilimab across blood cancers and solid tumours. Biotech investors often reposition after such events as they digest the data and …
Fruitflow is a natural extract from tomatoes that has been shown in human trials to reduce the propensity for aberrant blood clotting, which is associated with cardiovascular disease, heart attack and stroke. It is available as a spray-dried powder that can be included in …
LSE:TCF has been a popular retail stock, and news flow has accelerated in recent weeks with the appointment of a clinical partner in Australia and confirmation that the programme remains on track for clinic readiness by the end of 2026.
4basebio PLC (LSE:4BB) is being considered in the context of the FTSE AIM All-Share, where smaller listed businesses can react sharply to fresh disclosures, liquidity changes and shifts in risk appetite. The latest available review suggests the following focus: The proposed capital raise remains …